Skip to search formSkip to main contentSkip to account menu

Gefarnate

Known as: Gefarnate [Chemical/Ingredient], 4,8,12-Tetradecatrienoic acid, 5,9,13-trimethyl-, 3,7-dimethyl-2,6-octadienyl ester, (E,E,E)-, Farnesylacetate, Geranyl 
A water insoluble terpene fatty acid used in the treatment of gastrointestinal ulcers; it facilitates the healing and function of mucosal tissue.
National Institutes of Health

Related topics

Related topics

13 relations

Broader (1)

Anti-Ulcer Agent

Narrower (5)

GefarnilGepharnateUlcogefarnax
In Bloodagonistsanalogs & derivativesantagonists & inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
A new screening method for anti-ulcer agents: psychological stress produced by intraspecies emotional communication.
Psychological stress produced by intraspecies emotional communication in a communication box was studied to see whether it could… 
1985
1985
A comparison of alprazolam, gefarnate and their combination in treatment of peptic ulcer patients--an application of life table analysis.
One hundred and thirty-nine patients with endoscopically confirmed peptic ulcers (gastric and duodenal) entered a double blind… 
1983
1983
Effect of gefarnate on endogenous prostacyclin, prostaglandin E2 and thromboxane in water-immersed rats.
The level of endogenous prostacyclin (PGI2), prostaglandin E2 (PGE2) and thromboxane A2 (TXA2) in rat gastric mucosa was… 
1979
1979
Double blind comparison between cimetidine and gefarnate in cases of duodenal ulcer.
Thirty outpatients suffering from duodenal ulcer of recent onset were given cimetidine 1 g/day or gefarnate 250 mg/day for 6… 
1979
1979
Studies on the mechanism of action of cetraxate [4'-(2-carboxyethyl)phenyl trans-4-aminomethyl cyclohexanecarboxylate hydrochloride], a new anti-ulcer agent.
To elucidate mechanisms involved in the anti-ulcer action of cetraxate, the effects of this agent on the ulcer index (UI… 
1976
1976
Relation of Recurrence of Gastric Ulcers to Fundal Gastritis and Effect of Gefarnate in Preventing Recurrence
Summary The extents of fundal gastritis in 136 out-patients with healed gastric ulcers were examined by the endoscopic Congo red… 
1976
1976
Treatment of chronic gastric ulcer with gefarnate: a long-term controlled therapeutic trial.
A long-term controlled therapeutic trial of gefarnate (600 mg daily) in the treatment of chronic gastric ulcer was carried out in… 
1974
1974
Proceedings: A double blind trial of carbenoxolone and geranyl farnesylacetate in gastric ulcer.
1972
1972
Effect of anti-ulcer drugs on gastric mucous hexosamine in rats subjected to several ulcerogenic conditions.
Hexosamine content of pyloric tissue of the stomach in rats exposed to fasting, water immersion and restraint stress, and… 
1963
1963
[CLINICAL EVALUATION OF A NEW ANTI-ULCER PRODUCT (GERANYL FARNESYLACETATE)].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)